About Us

Contact Us

RCC
Home About Us Product News Order Career Contact

                                                                                                            

   

       

 

                          

Ticagrelor (Brilinta) Gains FDA Approval

 
 

         Ticagrelor(274693-27-5) (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.

Declaration
 
Time:2011-04-08
Home About Us Product News Order Career Contact
 Copyright @ 2010-2011 APIs All rights reserved
 

 

 

No_Right_Click

 

No_Right_Click